Ctc-310
NDC Package 48142-200-40

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Ctc-310 is according to the FDA reference text “Clarkes’ Materia Medica 1900”;Crotalus venom preparations are indicated as homeopathic medications for numerous conditions but especially; Cancers. Marketed by Celtic Biotech Iowa, Inc., this product is identified by NDC 48142-200.

Identification & Billing

NDC Package Code
48142-200-40
Package Description
10 mL in 1 VIAL, MULTI-DOSE
Product Code
48142-200
11-Digit Billing Format
48142020040

Clinical Specifications

Proprietary Name
Ctc-310
Dosage Form
-
Usage Information
According to the FDA reference text “Clarkes’ Materia Medica 1900”;Crotalus venom preparations are indicated as homeopathic medications for numerous conditions but especially; Cancers. Tongue, inflammation of ; cancer of. Clinical experience shows that Crotoxin also provide relief from some forms of pain.Cobra venom preparations are indicated as homeopathic medications for several conditions but especially for; angina faucium, angina pectoris, asthma, dysmenia (painful menses), grief (depression), headache (migraine), pain in ovaries (ovarian cysts), spinal irritation (back pain) and sore throat. Cardiotoxin is the principal active analgesic component.

Regulatory & Marketing

Labeler Name
Celtic Biotech Iowa, Inc.
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
04-30-2018
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 48142-200-40 identifies a specific commercial package of 10 ml in 1 vial, multi-dose of Ctc-310, labeled by Celtic Biotech Iowa, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Celtic Biotech Iowa, Inc. on April 30, 2018. The current certification is valid through December 31, 2019.

How is this Celtic Biotech Iowa, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 48142020040. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
48142-200-40
11-Digit CMS (5-4-2)
48142-0200-40

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.